Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses that are at an early stage in the medical sector including Drug and vaccine development; Diagnostics; Immuno-therapy; and Cell and gene therapies.
| Last: | $0.02135 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.02135 |
| Close: | $0.02135 |
| High: | $0.02135 |
| Low: | $0.02135 |
| Volume: | 1,000 |
| Last Trade Date Time: | 07/14/2025 09:30:02 am |
| Market Cap: | $2,369,555 |
|---|---|
| Float: | 87,184,977 |
| Insiders Ownership: | 20.2% |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.roquefortinvest.com |
| Country: | GB |
| City: | London |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Roquefort Therapeutics (OTCMKTS: ROQAF).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.